Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Now Rated “Hold” by Wall Street Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average rating of “Hold” from the fifteen ratings firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $32.54.

A number of analysts have recently issued reports on the stock. Leerink Partners raised their price target on shares of Acadia Healthcare from $30.00 to $33.00 and gave the stock a “market perform” rating in a report on Wednesday, September 23rd. Raymond James Financial cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price objective on the stock. in a report on Monday, September 28th. Royal Bank Of Canada upped their price objective on Acadia Healthcare from $31.00 to $41.00 and gave the company an “outperform” rating in a report on Friday. KeyCorp increased their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Finally, Cantor Fitzgerald raised their target price on Acadia Healthcare from $30.00 to $39.00 and gave the stock a “neutral” rating in a research note on Friday.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds have recently modified their holdings of the business. Allworth Financial LP increased its position in shares of Acadia Healthcare by 30.8% in the 3rd quarter. Allworth Financial LP now owns 1,976 shares of the company’s stock valued at $58,000 after purchasing an additional 465 shares during the last quarter. Pinnacle Wealth Planning Services Inc. lifted its position in shares of Acadia Healthcare by 20.7% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock worth $88,000 after purchasing an additional 550 shares during the last quarter. Global Retirement Partners LLC acquired a new position in shares of Acadia Healthcare during the second quarter worth $68,000. Integrated Wealth Concepts LLC acquired a new position in shares of Acadia Healthcare during the second quarter worth $79,000. Finally, Quantbot Technologies LP purchased a new position in Acadia Healthcare in the second quarter valued at $88,000.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

Acadia Healthcare Price Performance

NASDAQ ACHC opened at $37.00 on Monday. The business’s fifty day simple moving average is $29.40 and its 200-day simple moving average is $26.14. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The firm has a market cap of $3.44 billion, a PE ratio of -2.97, a P/E/G ratio of 10.57 and a beta of 0.64. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $39.38.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. The firm had revenue of $895.31 million during the quarter, compared to analyst estimates of $877.76 million. During the same quarter in the prior year, the firm posted $0.72 earnings per share. Acadia Healthcare’s quarterly revenue was up 5.1% on a year-over-year basis. As a group, equities analysts anticipate that Acadia Healthcare will post 1.75 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care.

Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program.

Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.